BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 11857106)

  • 21. Outcomes of Endoscopic Surveillance in Individuals With Genetic Predisposition to Hereditary Diffuse Gastric Cancer.
    Jacobs MF; Dust H; Koeppe E; Wong S; Mulholland M; Choi EY; Appelman H; Stoffel EM
    Gastroenterology; 2019 Jul; 157(1):87-96. PubMed ID: 30935944
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Familial gastric cancer].
    Nihei Z; Iida S; Sugihara K
    Nihon Rinsho; 2000 Jul; 58(7):1523-6. PubMed ID: 10921336
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Hereditary gastric cancer.
    Oliveira C; Seruca R; Carneiro F
    Best Pract Res Clin Gastroenterol; 2009; 23(2):147-57. PubMed ID: 19414142
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The power of genetics to target surgical prevention.
    Weitzel JN; McCahill LE
    N Engl J Med; 2001 Jun; 344(25):1942-4. PubMed ID: 11419434
    [No Abstract]   [Full Text] [Related]  

  • 25. Total Gastrectomy for Hereditary Diffuse Gastric Cancer at a Single Center: Postsurgical Outcomes in 41 Patients.
    Strong VE; Gholami S; Shah MA; Tang LH; Janjigian YY; Schattner M; Selby LV; Yoon SS; Salo-Mullen E; Stadler ZK; Kelsen D; Brennan MF; Coit DG
    Ann Surg; 2017 Dec; 266(6):1006-1012. PubMed ID: 27759617
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Screening E-cadherin in gastric cancer families reveals germline mutations only in hereditary diffuse gastric cancer kindred.
    Oliveira C; Bordin MC; Grehan N; Huntsman D; Suriano G; Machado JC; Kiviluoto T; Aaltonen L; Jackson CE; Seruca R; Caldas C
    Hum Mutat; 2002 May; 19(5):510-7. PubMed ID: 11968083
    [TBL] [Abstract][Full Text] [Related]  

  • 27. CDH1 associated gastric cancer: a report of a family and review of the literature.
    Moran CJ; Joyce M; McAnena OJ
    Eur J Surg Oncol; 2005 Apr; 31(3):259-64. PubMed ID: 15780560
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Novel germline CDH1 mutations in hereditary diffuse gastric cancer families.
    Humar B; Toro T; Graziano F; Müller H; Dobbie Z; Kwang-Yang H; Eng C; Hampel H; Gilbert D; Winship I; Parry S; Ward R; Findlay M; Christian A; Tucker M; Tucker K; Merriman T; Guilford P
    Hum Mutat; 2002 May; 19(5):518-25. PubMed ID: 11968084
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Characterization of the P373L E-cadherin germline missense mutation and implication for clinical management.
    Corso G; Roviello F; Paredes J; Pedrazzani C; Novais M; Correia J; Marrelli D; Cirnes L; Seruca R; Oliveira C; Suriano G
    Eur J Surg Oncol; 2007 Nov; 33(9):1061-7. PubMed ID: 17434710
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Indications for Total Gastrectomy in CDH1 Mutation Carriers and Outcomes of Risk-Reducing Minimally Invasive and Open Gastrectomies.
    Vos EL; Salo-Mullen EE; Tang LH; Schattner M; Yoon SS; Gerdes H; Markowitz AJ; Mandelker D; Janjigian Y; Offitt K; Coit DG; Stadler ZK; Strong VE
    JAMA Surg; 2020 Nov; 155(11):1050-1057. PubMed ID: 32997132
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Hereditary diffuse gastric cancer: implications of genetic testing for screening and prophylactic surgery.
    Cisco RM; Ford JM; Norton JA
    Cancer; 2008 Oct; 113(7 Suppl):1850-6. PubMed ID: 18798546
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Role of pathology in the identification of hereditary diffuse gastric cancer: report of a Portuguese family.
    Oliveira C; Moreira H; Seruca R; de Oliveira MC; Carneiro F
    Virchows Arch; 2005 Feb; 446(2):181-4. PubMed ID: 15735979
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Hereditary diffuse gastric cancer associated with E-cadherin germline mutation: a case report.
    Black MD; Kaneshiro R; Lai JI; Shimizu DM
    Hawaii J Med Public Health; 2014 Jul; 73(7):204-7. PubMed ID: 25089230
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Evidence expands total gastrectomy decision for asymptomatic patients with CDH1 inherited mutations.
    Liakakos T
    Ann Surg Oncol; 2011 Dec; 18 Suppl 3():S206-7; author reply S208. PubMed ID: 21681377
    [No Abstract]   [Full Text] [Related]  

  • 35. Germline E-cadherin gene mutations: is prophylactic total gastrectomy indicated?
    Chun YS; Lindor NM; Smyrk TC; Petersen BT; Burgart LJ; Guilford PJ; Donohue JH
    Cancer; 2001 Jul; 92(1):181-7. PubMed ID: 11443625
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prophylactic gastrectomy for hereditary diffuse gastric cancer syndrome.
    Newman EA; Mulholland MW
    J Am Coll Surg; 2006 Apr; 202(4):612-7. PubMed ID: 16571431
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Hereditary diffuse gastric cancer associated with E-cadherin mutation: penetrance after all.
    Gaya DR; Stuart RC; Going JJ; Stanley AJ
    Eur J Gastroenterol Hepatol; 2008 Dec; 20(12):1249-51. PubMed ID: 18989144
    [No Abstract]   [Full Text] [Related]  

  • 38. Prophylactic total gastrectomy for familial gastric cancer.
    Lewis FR; Mellinger JD; Hayashi A; Lorelli D; Monaghan KG; Carneiro F; Huntsman DG; Jackson CE; Caldas C
    Surgery; 2001 Oct; 130(4):612-7; discussion 617-9. PubMed ID: 11602891
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Chromoendoscopic surveillance in hereditary diffuse gastric cancer: an alternative to prophylactic gastrectomy?
    Shaw D; Blair V; Framp A; Harawira P; McLeod M; Guilford P; Parry S; Charlton A; Martin I
    Gut; 2005 Apr; 54(4):461-8. PubMed ID: 15753528
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Hereditary diffuse gastric cancer: diagnosis and management.
    Blair V; Martin I; Shaw D; Winship I; Kerr D; Arnold J; Harawira P; McLeod M; Parry S; Charlton A; Findlay M; Cox B; Humar B; More H; Guilford P
    Clin Gastroenterol Hepatol; 2006 Mar; 4(3):262-75. PubMed ID: 16527687
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.